DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 55 filers reported holding DERMA SCIENCES INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $1,421,000 | -3.0% | 310,987 | 0.0% | 0.00% | -20.0% |
| Q3 2015 | $1,465,000 | -34.2% | 310,987 | 0.0% | 0.01% | -28.6% |
| Q2 2015 | $2,227,000 | +55.1% | 310,987 | +83.5% | 0.01% | +40.0% |
| Q1 2015 | $1,436,000 | -9.0% | 169,496 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $1,578,000 | +11.8% | 169,496 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $1,412,000 | +76.1% | 169,496 | +144.2% | 0.01% | +66.7% |
| Q2 2014 | $802,000 | – | 69,412 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,148,292 | $13,275,000 | 5.90% |
| DAFNA Capital Management LLC | 384,794 | $4,448,000 | 4.22% |
| Consonance Capital Management LP | 1,451,692 | $16,782,000 | 2.50% |
| Broadfin Capital, LLC | 3,648,754 | $42,180,000 | 2.08% |
| Redmile Group, LLC | 600,677 | $6,944,000 | 0.84% |
| ORACLE INVESTMENT MANAGEMENT INC | 492,796 | $5,696,722,000 | 0.69% |
| Senvest Management, LLC | 593,665 | $6,863,000 | 0.60% |
| HealthCor Management, L.P. | 920,000 | $10,635,000 | 0.53% |
| Baker Brothers Advisors | 3,537,137 | $40,889,000 | 0.50% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 112,117 | $1,296,000 | 0.50% |